FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 28, 2016

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

FOXP1Mental Retardation With Language Impairment and With or Without Autistic FeaturesAutism Spectrum Disorder

Trial Locations (1)

RECRUITING

The Seaver Autism Center for Research and Treatment, New York

All Listed Sponsors

collaborator

The Seaver Foundation

UNKNOWN

collaborator

Autism Science Foundation

OTHER

collaborator

Research Foundation for Mental Hygiene, Inc.

OTHER

lead

Icahn School of Medicine at Mount Sinai

OTHER